Trademark: HEPLISAV-B
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
Proof of use for HEPLISAV-B
We do not have any records of a proof of use for HEPLISAV-B at this moment.
Possible trademark infringements of HEPLISAV-B
Basic Information about HEPLISAV-B
- Serial Number
- 98014166
- Filing Date
- 25 May 2023
- Mark Drawing Code
- 3
Classifications
Declare the trademark use of HEPLISAV-B on the blockchain with WikiTrademarks.io.
- First use of HEPLISAV-B anywhere
- HEPLISAV-B was first used on 23 Aug 2018 for the primary classification of goods and services, international, 005 (Pharmaceuticals)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 005
- US Codes
- 005; 006; 018; 044; 046; 051; 052
Who owns HEPLISAV-B?
1. Dynavax Technologies Corporation Emeryville CA
2. Dynavax Technologies Corporation Emeryville CA
Correspondent
- BETH M. GOLDMAN
- ORRICK, HERRINGTON & SUTCLIFFE LLP
- IP PROSECUTION DEPARTMENT
- 2050 MAIN STREET, SUITE 1100
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io